Delivery Order SPE2DR25D9314-SPE2DR26FKNM7
Award Date 3/6/26
Potential Completion Date 3/27/26
Potential Value $1.3K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency issued a $12,590.80 delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, on February 5, 2026, under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) for YF-VAX 1 dose vials. PPV-G GEN V is a Defense Logistics Agency indefinite delivery contract authorizing firm fixed-price calls for pharmaceutical products, biologics, and medical consumables to support Department of Defense military healthcare facilities worldwide....
- The Defense Logistics Agency issued a $2,518.16 delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, on February 2, 2026, under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) for YF-VAX 1 dose vials. PPV-G GEN V is a Defense Logistics Agency indefinite delivery contract authorizing firm fixed-price delivery orders for pharmaceutical products, biologics, and medical consumables to support Department of Defense military healthcare facilities...
- The Defense Logistics Agency issued a $2,518.16 delivery order to DMS Pharmaceutical Group Inc. on March 4, 2026, under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) for YF-VAX 1 dose vials with an ultimate completion date of March 25, 2026. PPV-G GEN V is the Defense Logistics Agency's pharmaceutical prime vendor program structured to provide firm fixed-price delivery orders for branded and generic prescription drugs, over-the-counter medications, biologics,...
- The Defense Logistics Agency issued a $2,227.04 delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, on November 4, 2025, for YF-VAX 1 dose vials under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V). PPV-G GEN V is a Defense Logistics Agency indefinite delivery contract authorizing firm fixed-price delivery orders for pharmaceutical products, biologics, and medical consumables to support Department of Defense healthcare operations globally....
- The Defense Logistics Agency issued a $6,295.40 delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, on February 18, 2026, for YF-VAX 1 dose vials under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V). PPV-G GEN V is a Defense Logistics Agency indefinite delivery contract authorizing firm fixed-price delivery orders for pharmaceutical products, biologics, and medical consumables to support military healthcare facilities worldwide. Place of...
- The Defense Logistics Agency issued a $2,518.16 delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, on February 17, 2026, for YF-VAX 1-dose vials under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V). PPV-G GEN V is the Defense Logistics Agency's indefinite delivery contract authorizing firm fixed-price delivery orders for pharmaceutical products, biologics, and medical consumables to support Department of Defense healthcare operations...
- The Defense Logistics Agency issued a $3,147.70 delivery order to DMS Pharmaceutical Group Inc. on March 5, 2026, for YF-VAX 1-dose vials under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V). PPV-G GEN V is a Defense Logistics Agency indefinite delivery contract authorizing firm fixed-price delivery orders for branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables to support Department of Defense healthcare operations...
- The Defense Logistics Agency issued a $6,295.40 delivery order to DMS Pharmaceutical Group Inc. on February 6, 2026, for YF-VAX 1 dose vials under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V). PPV-G GEN V is a Defense Logistics Agency indefinite delivery contract authorizing firm fixed-price delivery orders for pharmaceutical products and medical consumables to support Department of Defense military healthcare facilities worldwide. DMS Pharmaceutical Group Inc. is...
- The Defense Logistics Agency issued a $6,295.40 delivery order to DMS Pharmaceutical Group Inc. on February 6, 2026, for YF-VAX 1 dose vials under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V). PPV-G GEN V is a Defense Logistics Agency indefinite delivery contract authorizing firm fixed-price delivery orders for a comprehensive range of pharmaceutical products including branded and generic prescription drugs, over-the-counter medications, biologics, and medical...
- The Defense Logistics Agency issued a $12,590.80 delivery order to DMS Pharmaceutical Group Inc. on March 3, 2026, for YF-VAX 1 dose vials under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) contract. The PPV-G GEN V is a Defense Logistics Agency indefinite delivery contract authorizing firm fixed-price delivery orders for a comprehensive range of pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics, and...